Cystagon 50 (Cysteamine Capsule) 50mg

Cystagon 50 is a cysteamine capsule used to manage nephropathic cystinosis, a rare genetic disorder. This medication helps reduce cystine buildup in cells. Store below 25°C and keep out of reach of children. Always follow healthcare provider guidance.

Strength

50mg

Pack Size

100s

Storage

Below 25°C

Manufacturer / TM Owner

Recordati

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cystagon 50 is primarily used to treat nephropathic cystinosis, a condition where cystine accumulates in cells due to a genetic defect. It helps reduce cystine levels in the body, slowing damage to organs like the kidneys and eyes. This medication is often prescribed as part of a long-term treatment plan. It may also be used to address other conditions as determined by a healthcare professional.

Side Effects

Cystagon 50 capsules work by binding to cystine in the body, allowing it to be safely removed. This process helps prevent the buildup of cystine crystals in tissues and organs. Common effects include improved kidney function and reduced eye-related complications over time. Patients may notice gradual changes in their condition with consistent use.

Precautions & Warnings

Store Cystagon 50 capsules below 25°C in a dry place, away from moisture and heat. Keep the medication in its original packaging and out of reach of children and pets. Avoid crushing or opening capsules unless instructed by a healthcare provider. Report any unusual side effects or concerns to a medical professional promptly.

Avoid Interactions

Cystagon 50 may interact with other medications, including those that affect stomach acid or kidney function. It is important to inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using. Alcohol and certain foods may also affect how the medication works. Always consult a doctor before combining treatments.

Frequently Asked Questions

Cystagon 50 is used to treat nephropathic cystinosis by reducing cystine buildup in cells.

Store below 25°C in a dry place, away from moisture and heat, in the original packaging.

Do not open or crush the capsule unless instructed by a healthcare provider.

Common effects may include gastrointestinal discomfort or changes in kidney function.

No, Cystagon 50 requires a prescription from a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.